本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Propanc Biopharma, Inc.

0.9210
-0.0218-2.31%
盤後0.9010-0.0200-2.17%19:38 EDT
成交量:22.97萬
成交額:20.82萬
市值:322.64萬
市盈率:-0.03
高:0.9349
開:0.9222
低:0.8744
收:0.9428
52周最高:62.50
52周最低:0.8744
股本:350.31萬
流通股本:125.01萬
量比:1.01
換手率:18.37%
股息:- -
股息率:- -
每股收益(TTM):-32.4560
每股收益(LYR):-371.2241
淨資產收益率:-126.98%
總資產收益率:-62.31%
市淨率:0.33
市盈率(LYR):0.00

資料載入中...

2021/01/11

重要事件披露

8-K - Current report
2020/12/30

重要事件披露

8-K - Current report
2020/12/16

重要事件披露

8-K - Current report
2020/12/07

重要事件披露

8-K - Current report
2020/11/19

重要事件披露

8-K - Current report
2020/11/16

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/10

SEC問詢函

CORRESP [Cover] - Correspondence
2020/11/03

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/11/03

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/14

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/10/01

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/08/13

SEC問詢函

CORRESP [Cover] - Correspondence
2020/08/13

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/07/22

SEC問詢函

CORRESP [Cover] - Correspondence
2020/07/17

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/07/16

SEC問詢函

CORRESP [Cover] - Correspondence
2020/07/07

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/07/07

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/07/02

SEC問詢函

CORRESP [Cover] - Correspondence
2020/06/26

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933